In vitro diagnostics manufacturer integrating enterprise systems across global operations
Diasorin manufactures diagnostic reagent kits and life science products across 35 companies and 10 manufacturing facilities worldwide. The tech stack reveals a traditional enterprise architecture (SAP, Salesforce, Oracle) now undergoing modernization—adopting SAP S/4HANA and SD while integrating Salesforce into core workflows. Hiring concentrates heavily on manufacturing and engineering roles, paired with active projects on instrument development, supplier quality, and POC market expansion, signaling operational scale-up across both product lines and geographic footprint.
Diasorin is a publicly listed Italian diagnostics company specializing in in vitro diagnostic (IVD) testing and life science reagents. Founded over 50 years ago and headquartered in Saluggia, the company operates through a distributed global footprint: 35 subsidiary companies, 4 branches, 10 manufacturing facilities, and 9 R&D centers spanning five continents. The portfolio spans immunoassay, molecular diagnostics, blood testing, infectious disease screening, and prenatal diagnostics. With over 3,200 employees including 400+ researchers, Diasorin sells to diagnostic laboratories and healthcare systems. Current operational priorities include expanding non-acute point-of-care offerings, upgrading manufacturing throughput, and post-M&A integration activities.
Diasorin runs SAP, Salesforce, Oracle, and Microsoft Office. It is currently adopting SAP S/4HANA and SAP SD modules, with an active integration project connecting SAP SD to Salesforce workflows.
Active projects include non-acute POC portfolio adoption, M&A integration, new product launches, instrument development, and supplier quality programs. Internal challenges include manufacturing throughput, GDPR compliance, and product consistency across distributed operations.
Other companies in the same industry, closest in size